Jose Eustasio Meca Lallana

Millan-Pascual J, Valero-Lopez G, Iniesta-Martinez F, Hellin-Gil MF, Jimenez-Veiga J, Lopez-Tovar IA, Morales-Ortiz A, Meca-Lallana JE. Humoral Response to SARS-COV-2 Vaccination in Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Real-World Study. Neurol Ther. 2024 Feb;13(1):153-164. doi: 10.1007/s40120-023-00572-8. Epub 2023 Dec 14. PubMed PMID: 38097868; PubMed Central PMCID: PMC10787726.

AÑO: 2024; IF: 3.7

38097868

Carreon Guarnizo E, Hernandez Clares R, Castillo Trivino T, Meca Lallana V, Arocas Casan V, Iniesta Martinez F, Olascoaga Urtaza J, Meca Lallana JE. Experience with tocilizumab in patients with neuromyelitis optica spectrum disorders. Neurologia (Engl Ed). 2022 Apr;37(3):178-183. doi: 10.1016/j.nrleng.2018.12.021. Epub 2021 Feb 26. PubMed PMID: 35465911.

AÑO: 2022

35465911

Carreon Guarnizo E, Hernandez Clares R, Castillo Trivino T, Meca Lallana V, Arocas Casan V, Iniesta Martinez F, Olascoaga Urtaza J, Meca Lallana JE. Experience with tocilizumab in patients with neuromyelitis optica spectrum disorders. Neurologia (Engl Ed). 2022 Apr;37(3):178-183. doi: 10.1016/j.nrl.2018.12.013. Epub 2019 Mar 28. English, Spanish. PubMed PMID: 30928236.

AÑO: 2022; IF: 2.283

30928236

Meca-Lallana JE, Fernandez-Prada M, Garcia Vazquez E, Moreno Guillen S, Otero Romero S, Rus Hidalgo M, Villar Guimerans LM, Eichau Madueno S, Fernandez Fernandez O, Izquierdo Ayuso G, Alvarez Cermeno JC, Arnal Garcia C, Arroyo Gonzalez R, Brieva Ruiz L, Calles Hernandez C, Garcia Merino A, Gonzalez Platas M, Hernandez Perez MA, Moral Torres E, Olascoaga Urtaza J, Oliva-Nacarino P, Oreja-Guevara C, Ortiz Castillo R, Oterino A, Prieto Gonzalez JM, Ramio-Torrenta L, Rodriguez-Antiguedad A, Saiz A, Tintore M, Montalban Gairin X. Consensus statement on the use of alemtuzumab in daily clinical practice in Spain. Neurologia (Engl Ed). 2020 Jan 25;37(8):615-630. doi: 10.1016/j.nrl.2019.11.003. Print 2022 Oct. English, Spanish. PubMed PMID: 31987648.

AÑO: 2022; IF: 3.109

31987648

Bar-Or A, Wiendl H, Montalban X, Alvarez E, Davydovskaya M, Delgado SR, Evdoshenko EP, Giedraitiene N, Gross-Paju K, Haldre S, Herrman CE, Izquierdo G, Karelis G, Leutmezer F, Mares M, Meca-Lallana JE, Mickeviciene D, Nicholas J, Robertson DS, Sazonov DV, Sharlin K, Sundaram B, Totolyan N, Vachova M, Valis M, Bagger M, Haring DA, Ludwig I, Willi R, Zalesak M, Su W, Merschhemke M, Fox EJ. Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study. Mult Scler. 2022 May;28(6):910-924. doi: 10.1177/13524585211044479. Epub 2021 Oct 4. PubMed PMID: 34605319; PubMed Central PMCID: PMC9024029.

AÑO: 2022; IF: 5.8

34605319